RESUMEN
Onychomycosis with longitudinal spikes in the nail plate has been reported to be refractory to oral drugs as with dermatophytoma. We evaluated the efficacy of 10% efinaconazole solution in the treatment of onychomycosis with longitudinal spikes. Of the 223 subjects who were enrolled in a previous study, a post-hoc analysis of 82 subjects with longitudinal spikes was performed in this study. The opacity ratio of longitudinal spikes was decreased over time from 8.1 to 0.9 at the final assessment. In addition, the longitudinal spike disappearance rate increased early after the application to 81.7% at the final assessment. Therefore, 10% efinaconazole solution can be a first-line drug for longitudinal spikes, which have been regarded as refractory to oral drugs.
Asunto(s)
Onicomicosis , Administración Tópica , Antifúngicos/uso terapéutico , Humanos , Onicomicosis/tratamiento farmacológico , Resultado del Tratamiento , TriazolesRESUMEN
We evaluated the efficacy of efinaconazole 10% topical solution in long-term use, for up to 72 weeks, for onychomycosis, including severe cases. Among 605 participants, 219 patients diagnosed as having onychomycosis were evaluated for the efficacy of efinaconazole. The treatment success rate (<10% clinical involvement of the target toenail) at the final assessment time point was 56.6%, the complete cure rate was 31.1% and the mycological cure rate was 61.6%, all of which increased over time, demonstrating that continuous application contributed to the improvement of cure rate. Even in severe cases, reduction of the affected nail area was observed, showing the potential efficacy of the treatment. Responses to a quality of life questionnaire among patients with onychomycosis, OnyCOE-t, suggested that efinaconazole treatment improved the patients' quality of life. The incidence of adverse drug reaction in the patients eligible for the assessment was 6.3%, and this developed only in the administration site in all cases. No systemic adverse event was observed. In addition, no increase in the incidence of adverse drug reaction due to long-term use was found. Efinaconazole therapy was proved to exhibit excellent balance between efficacy and safety, and thus may serve as a useful treatment option for onychomycosis.
Asunto(s)
Antifúngicos/administración & dosificación , Dermatosis del Pie/tratamiento farmacológico , Onicomicosis/tratamiento farmacológico , Triazoles/administración & dosificación , Administración Tópica , Anciano , Antifúngicos/efectos adversos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/epidemiología , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/etiología , Femenino , Dermatosis del Pie/diagnóstico , Humanos , Incidencia , Cuidados a Largo Plazo/métodos , Masculino , Persona de Mediana Edad , Onicomicosis/diagnóstico , Calidad de Vida , Índice de Severidad de la Enfermedad , Factores de Tiempo , Resultado del Tratamiento , Triazoles/efectos adversosRESUMEN
OBJECTIVES: Insulin-derived amyloidosis is a rare skin-related complication of insulin therapy. The purpose of this study was to show the effects of insulin-derived amyloidosis on blood glucose levels, insulin dose requirements, and insulin absorption. METHODS: Seven patients were found to have insulin-derived amyloidosis at the Tokyo Medical University Ibaraki Medical Center. The clinical characteristics and insulin therapy of the 7 patients were investigated. Insulin absorption was studied by comparing the serum insulin levels after insulin injections into insulin-derived amyloidosis sites versus injections into normal sites in 4 patients. RESULTS: When the insulin-derived amyloidosis was discovered, the mean hemoglobin A1c level was 9.3%, and the mean daily insulin dose was 57 units. After changing the injection sites to avoid the insulin-derived amyloidosis, the blood glucose concentrations improved, and the mean daily insulin dose could be reduced to 27 units (P = .035; 53% reduction). The insulin absorption at insulin-derived amyloidosis sites was 34% of that at normal sites (P = .030). CONCLUSIONS: Insulin-derived amyloidosis caused poor glycemic control and increased insulin dose requirements because of impairments in insulin absorption.
Asunto(s)
Amiloidosis/inducido químicamente , Glucemia/metabolismo , Diabetes Mellitus Tipo 2/sangre , Hipoglucemiantes/administración & dosificación , Hipoglucemiantes/efectos adversos , Insulina/administración & dosificación , Insulina/efectos adversos , Absorción , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Hemoglobina Glucada/metabolismo , Humanos , Hipoglucemiantes/sangre , Inyecciones Subcutáneas , Insulina/sangre , Japón , Masculino , Persona de Mediana EdadAsunto(s)
Cromatografía Líquida de Alta Presión/métodos , Frío , Nitratos/sangre , Nitritos/sangre , Enfermedad de Raynaud/sangre , Rayos Ultravioleta , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Cromatografía Líquida de Alta Presión/instrumentación , Femenino , Mano/fisiología , Humanos , Masculino , Persona de Mediana Edad , Inhibidores de Agregación Plaquetaria/uso terapéutico , Enfermedad de Raynaud/tratamiento farmacológico , Estrés Fisiológico/efectos de los fármacos , Estrés Fisiológico/fisiología , Succinatos/uso terapéutico , Adulto JovenRESUMEN
We report a case of cutaneous infection due to Scedosporium apiospermum in a 75-year-old immunocompromised male patient who had received long-term corticosteroid and immunosuppressant therapy for the treatment of nephrotic syndrome. The patient came to our department complaining of erythema with a number of pustules on the dorsal surface of the right hand. S. apiospermum was identified from a culture taken from the pus. After unsuccessful treatment with topical ketoconazole, oral itraconazole and oral terbinafine, the lesion quickly resolved with the daily administration of 400 mg voriconazole. No recurrence was observed despite discontinuation of voriconazole due to drug-induced hepatitis. Voriconazole holds out the promise of an effective treatment for invasive Scedosporium infection.
Asunto(s)
Antifúngicos/uso terapéutico , Huésped Inmunocomprometido , Micetoma/tratamiento farmacológico , Micetoma/microbiología , Pirimidinas/uso terapéutico , Scedosporium/aislamiento & purificación , Triazoles/uso terapéutico , Humanos , Inmunosupresores/efectos adversos , Masculino , Micetoma/inmunología , Síndrome Nefrótico/tratamiento farmacológico , VoriconazolAsunto(s)
Enfermedades del Cabello/diagnóstico por imagen , Cabello/ultraestructura , Microscopía Electrónica de Rastreo , Enfermedades del Cabello/diagnóstico , Enfermedades del Cabello/etiología , Enfermedades del Cabello/patología , Dispositivos de Protección de la Cabeza/efectos adversos , Humanos , Masculino , Ultrasonografía , Adulto JovenRESUMEN
In order to determine the collagen content of small amounts of skin tissue, we developed a new, simple and highly sensitive method of measuring the quantity of hydroxyproline (Hyp) using isocratic high performance liquid chromatography (HPLC) with a fluorogenic agent, 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-F). The recovery rate of Hyp and reproducibility of the assay were high, and the test was sensitive enough to detect Hyp in less than 1 mg of skin tissue. This method is clinically useful for ensuring accurate diagnosis and for monitoring specific skin conditions using small human skin samples collected in biopsies.
Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Hidroxiprolina/análisis , Piel/química , 4-Cloro-7-nitrobenzofurazano/análogos & derivados , 4-Cloro-7-nitrobenzofurazano/química , Aminoácidos/análisis , Aminoácidos/aislamiento & purificación , Animales , Diafragma/química , Colorantes Fluorescentes/química , Riñón/química , Hígado/química , Masculino , Músculos/química , Miocardio/química , Ratas , Ratas Sprague-Dawley , Reproducibilidad de los ResultadosAsunto(s)
Alérgenos/efectos adversos , Dermatitis Alérgica por Contacto/diagnóstico , Ácidos Nicotínicos/efectos adversos , Vitamina E/efectos adversos , Adulto , Dermatitis Alérgica por Contacto/etiología , Dermatitis Alérgica por Contacto/patología , Diagnóstico Diferencial , Femenino , Humanos , Pruebas del Parche , Vitamina E/análogos & derivadosAsunto(s)
Ciclosporina/farmacocinética , Fármacos Dermatológicos/farmacocinética , Inmunosupresores/farmacocinética , Lipoproteínas LDL/sangre , Obesidad/metabolismo , Psoriasis/metabolismo , Administración Oral , Anticolesterolemiantes/farmacología , Anticolesterolemiantes/uso terapéutico , Ciclosporina/uso terapéutico , Fármacos Dermatológicos/uso terapéutico , Sinergismo Farmacológico , Ácidos Grasos Monoinsaturados/farmacología , Ácidos Grasos Monoinsaturados/uso terapéutico , Femenino , Fluvastatina , Humanos , Hiperlipoproteinemia Tipo II/sangre , Hiperlipoproteinemia Tipo II/complicaciones , Inmunosupresores/uso terapéutico , Indoles/farmacología , Indoles/uso terapéutico , Persona de Mediana Edad , Obesidad/complicaciones , Psoriasis/complicaciones , Psoriasis/tratamiento farmacológicoRESUMEN
Plethysmogram has been widely known as a conventional non-invasive simple method to obtain information on peripheral circulatory kinetics. We made a quantitative assessment of the relationships between the various circulatory parameters, using the simple conventional measurement method of treating acceleration plethysmograms (the second derivatives of digital plethysmograms) as indicators of peripheral circulation kinetics. We designed a prototype model peripheral circulatory circuit, using an artificial heart, for the purpose of clarifying the relationship between physical factors and plethysmograms. In our models of the peripheral circulatory system, we made use of various types of matching silicon tubes, as well as canine carotid arteries, as substitutes for human arteries. We evaluated the mechanical characteristics, such as the pressure and volume characteristics of the silicon tubes and canine carotid arteries. Plethysmogram alterations were measured using a photoelectric digital plethysmogram. When we examined the acceleration plethysmogram b/a values, which indicate blood vessel extensibility and hardness, and the d/a values, which we were able to use as an index of peripheral circulatory kinetics, it was clear from out model testing that canine carotid arteries displayed b/a values that were closest to those found in the human fingertip; among artificial tubes, the closest was a tube with a diameter of 4 mm (0.18 mm in thickness). The b/a values of all types of tubes declined when the compliance of the arterial system was increased, and it was confirmed through model testing that b/a values are an indicator of blood vessel extensibility.
Asunto(s)
Circulación Asistida/instrumentación , Músculo Liso Vascular/fisiología , Pletismografía/instrumentación , Circulación Pulmonar/fisiología , Fenómenos Biomecánicos , Presión Sanguínea/fisiología , Adaptabilidad , Luz , Modelos AnatómicosRESUMEN
We report a case of an unusual form of cutaneous tuberculosis in an 82-year-old woman. She visited our hospital because of an intractable ulcer on the fifth finger of her right hand. While examining the ulcer surrounding half of her right fifth finger and covered with necrotic tissue, we also perceived a nodule with crust on the forearm, multiple subcutaneous nodules on the right forearm and upper arm, and a hen's-egg-sized agglomerative nodule on the axilla. All the lesions were located on her right arm. Skin biopsy specimens showed granulomatous tissue with necrosis in the lesions. Mycobacterium tuberculosis was identified by culture of a biopsied specimen, so the diagnosis was confirmed. Further examination revealed that she also had pulmonary tuberculosis. Cutaneous tuberculoses are classified morphologically with reference to host immune status, but no satisfactory classification exists. The present case can't be classified into any of the types which have been proposed so far. She is elderly and suffers from liver cirrhosis, hepatocellular carcinoma and myelodysplastic syndrome. The resulting acquired immunosuppression may have caused a unique form of cutaneous tuberculosis.
Asunto(s)
Huésped Inmunocomprometido , Tuberculosis Cutánea/diagnóstico , Anciano , Anciano de 80 o más Años , Brazo , Humanos , Masculino , Piel/patología , Úlcera Cutánea/microbiología , Tuberculosis Cutánea/complicaciones , Tuberculosis Cutánea/inmunología , Tuberculosis Cutánea/patología , Tuberculosis Pulmonar/complicacionesRESUMEN
We present a 56-year-old woman with a perforating pilomatricoma in the left eyebrow region. Histologically, the tumor consisted mainly of basophilic cells and shadow cells, and the tumor components were being eliminated through an ulcer with damage to the epithelial structures. In past reports of perforating pilomatricoma, this elimination pattern has often been described as transepithelial elimination. In many patients with perforating pilomatricoma, elimination is accompanied by ulceration and epithelial damage. Mehregan recently stated that elimination accompanied by epidermal necrosis and superficial ulceration constituted one form of transepithelial elimination. Epidermal necrosis and ulceration generally constitute severe damage. However, when Mehregan first proposed the concept of transepithelial elimination, it was defined as a phenomenon with relatively little or no damage to the epithelial structures, differentiating it from other types of elimination. This original definition makes transepithelial elimination a unique and interesting phenomenon, and its most important feature is that there is relatively little or no damage to the epithelial structures. Therefore, the terms "epidermal necrosis" and "ulceration" should not be used in association with transepithelial elimination. Hence, in patients with perforating pilomatricoma, the elimination of tumor components from ulcers with damage to the epithelial structures, as seen in the present case, should not be described as transepithelial elimination.
Asunto(s)
Enfermedades del Cabello/patología , Enfermedades del Cabello/cirugía , Pilomatrixoma/patología , Pilomatrixoma/cirugía , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/cirugía , Biopsia con Aguja , Legrado/métodos , Electrocirugia , Epitelio/patología , Epitelio/cirugía , Cejas , Femenino , Humanos , Persona de Mediana Edad , Pronóstico , Medición de Riesgo , Resultado del TratamientoRESUMEN
An asymptomatic nodule appeared in the right temporal region of an 81-year-old woman. Histopathologic examination confirmed significant thickening of the vascular wall, constriction of the vessel lumen, and infiltration of numerous eosinophils and lymphocytes. Giant cells were not seen. Lymphoid follicles and capillaries surrounded the large vessel. Elastica van Gieson staining revealed a laceration of the internal elastic lamina. Based on these clinical and histologic findings, the patient was diagnosed as having juvenile temporal arteritis (JTA), a disease first proposed by Lie and his colleagues in 1975. Three years later, a new eruption, again asymptomatic, appeared in the posterior region of the patient's right ear. Subsequently, she was referred to our department. Histologic examination of the new lesion confirmed the infiltration of lymphocytes and eosinophils, which was accompanied by numerous lymphoid follicles, and the proliferation of endothelial cells and capillaries from the deep dermis to the subcutaneous tissue. The patient was diagnosed as having Kimura disease, which is a persistent and recurrent illness. We hypothesized that JTA was a partial expression of Kimura disease and investigated whether past cases of JTA could be considered Kimura disease. As a result, we found that most cases of JTA could indeed be considered Kimura disease. Furthermore, we examined the vascular changes in the routinely and elastic fiber-stained sections of three cases with Kimura disease and two cases with angiolymphoid hyperplasia with eosinophilia. The results showed occlusive vascular changes in most samples from these cases, supporting the hypothesis that JTA is an accessory lesion of Kimura disease.